Concepedia

Jozal Moore

JM

Statistics

Publications

4

Citations

79

H-Index

4

Active since

2021

Affiliations

Moffitt Cancer Center(Current)

Augusta University Health

University of Minnesota

University of Southern California

Northside Hospital

Jozal Moore is an author at Moffitt Cancer Center specializing in b-cell targeted therapy, hematology, and chimeric antigen receptor t-cell therapy.

Publications per year

2021–2024

4

Publications

4

Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL

Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Life Sciences, Hematology, Immunology +13

Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia

Ari Pelcovits, Jozal Moore, Brianna R. Bakow et al. · Supportive Care in Cancer · 2021 · 23 citations

Medicine, Hematology, Oncology +10

Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell ALL: Outcomes and Novel Insights from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)

Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar et al. · Blood · 2023 · 14 citations

Life Sciences, Immunology, Oncology +13

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand et al. · Blood Advances · 2024 · 10 citations · Full text

Medicine, Hematology, Oncology +14

1–4 of 4